Isolation, Culture, and Induced Differentiation of Bone Marrow Mesenchymal Stem Cells into Osteoclasts: Experimental Procedure

I. Principle

(1) Principle of Isolation and Enrichment of BMSCs

Bone marrow tissue contains multiple cell types, including hematopoietic stem cells, mesenchymal stem cells, monocytes, and lymphocytes. Density gradient centrifugation allows separation of the mononuclear cell layer based on density differences. Utilizing the plastic adherence property of mesenchymal stem cells, long-term culture in serum-containing medium with repeated medium changes removes non-adherent or weakly adherent blood-derived cells, resulting in relatively enriched and morphologically uniform BMSCs.

(2) Mechanism of Cytokine-Induced Osteoclast Differentiation

In vitro, bone marrow–derived mononuclear cells can differentiate into osteoclast-like multinucleated cells under the combined stimulation of M-CSF (macrophage colony-stimulating factor) and RANKL (receptor activator of NF-κB ligand).

M-CSF, through its receptor c-Fms, promotes proliferation, survival, and differentiation of monocyte/macrophage progenitors, providing sufficient precursors for osteoclastogenesis.

RANKL binds to its receptor RANK, activating key signaling pathways such as NF-κB, MAPK, and NFATc1, which drive the expression of osteoclast-specific genes (e.g., TRAP, Cathepsin K) and promote cell fusion into multinucleated osteoclasts.

II. Materials and Reagents

(1) Experimental Animals

Mice

(2) Reagents

Heparin or EDTA anticoagulant

PBS buffer

Density gradient medium (e.g., Ficoll/Percoll)

DMEM medium

α-MEM medium

Fetal bovine serum (FBS)

Penicillin–streptomycin (P/S, optional)

M-CSF (working concentration 20–50 ng/mL)

RANKL (working concentration 50–100 ng/mL)

Trypsin-EDTA digestion solution

TRAP staining kit

Sterile distilled/deionized water

(3) Consumables and Equipment

Sterile syringes and needles

Sterile centrifuge tubes (15 mL, 50 mL)

40 μm cell strainer

Cell culture flasks (T25/T75, etc.)

24-well plates (or other multiwell formats)

Pipettes and sterile tips

Microcentrifuge tubes

Hemocytometer or automatic cell counter

CO₂ incubator

Tabletop centrifuge

Biosafety cabinet/clean bench

Inverted microscope (upright microscope for TRAP observation)

III. Isolation and Separation of BMSCs

(1) Sample Collection: Under sterile conditions, anesthetize the mouse and expose the femur or tibia. Using a syringe, aspirate bone marrow from the medullary cavity and immediately inject into a sterile centrifuge tube containing heparin or EDTA anticoagulant.

(2) Dilution and Filtration: Mix bone marrow with an equal volume of PBS and filter through a 40 μm cell strainer. Collect the filtrate in a centrifuge tube.

(3) Density Gradient Centrifugation: Add appropriate density gradient medium into a centrifuge tube, and slowly layer the diluted marrow onto it without mixing. Centrifuge at 400 g for 20 min. After centrifugation, carefully collect the mononuclear cell layer at the interface with a pipette and transfer it to a new tube.

(4) Cell Washing: Add ~10 mL PBS to resuspend the cells and centrifuge at 400 g for 5 min. Discard the supernatant and repeat the wash 1–2 times.

(5) Cell Seeding and Culture: Resuspend the cell pellet in DMEM containing 10–20% FBS, and seed at a density of 1–2×10⁶ cells/cm² in culture flasks. Incubate at 37°C with 5% CO₂. After 24–48 h, replace the medium to remove non-adherent cells. Change the medium every 2–3 days until cells reach 70–80% confluence.

IV. Induced Differentiation of BMSCs into Osteoclasts

(1) Cell Preparation: When BMSCs reach the desired confluence, digest with trypsin and collect cells. Seed at appropriate density in new culture vessels (e.g., 24-well plates) using α-MEM medium containing 20–50 ng/mL M-CSF.

(2) Induction: After 12 h (allowing attachment), replace the medium with α-MEM containing 10% FBS, 20–50 ng/mL M-CSF, and 50–100 ng/mL RANKL. Change the medium every 24 h and continue induction for 6–8 days.

(3) Osteoclast Identification: After induction, perform TRAP staining according to the kit instructions. Under the microscope, identify TRAP-positive cells: multinucleated (≥3 nuclei) and showing deep red to purple cytoplasm indicate osteoclasts.

V. Common Questions and Troubleshooting

Q1: BMSCs show morphological degeneration and reduced induction efficiency after several passages.

A: This usually results from cellular senescence. It is recommended to perform induction within passages P2–P4. If high-passage cells must be used, clearly note passage number in records and publications, and discuss this limitation. When cells become enlarged, elongated, vacuolated, or proliferate slowly, discard and restart cultures.

Q2: Few TRAP-positive or multinucleated cells appear after adding M-CSF and RANKL.

A: Check storage conditions of M-CSF and RANKL—avoid multiple freeze–thaw cycles or expired reagents. Increase seeding density if viable, and optimize cytokine concentrations within M-CSF (20–50 ng/mL) and RANKL (50–100 ng/mL) ranges. Induction time may vary; some systems peak at days 5–7—observe multiple time points (e.g., day 4, 6, 8). Evaluate effects of serum batch variation if efficiency drops after changing FBS.

Q3: Extensive cell death or detachment during induction.

A: Examine under phase-contrast microscopy for contamination (bacterial, fungal, mycoplasma). If contaminated, discard immediately. If not, check initial seeding density—too high density can cause nutrient depletion and pH fluctuation. Ensure gentle medium exchange; avoid direct pipette flow onto cells. Cytokine overdose or improper combination may induce stress—reduce doses or shorten induction duration as needed.

Q4: TRAP staining shows excessive background or very weak color.

A: For dark background: over-fixation or too concentrated fixative may be responsible—shorten fixation and strictly follow reagent instructions. Control TRAP reaction time; pretest 10, 20, and 30 min intervals. For weak staining: confirm that the TRAP working solution is freshly prepared, pH is within the recommended range, and reagents are active. When intrinsic TRAP expression is low, prolong induction or slightly increase RANKL concentration to enhance osteoclastic phenotype expression.

Aladdin: https://www.aladdinsci.com/